ArticleCurrent molecular medicine2026

ELOVL4 is a Prognostic Biomarker with Implications for Immune Modulation and Therapeutic Response in Gastric Cancer.

Yuxin Chu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.